Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2250 of 2529 entries
View as:

A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06311383 Org: User:
Start: 10/09/17 End: 02/16/25 Due: 02/16/26

An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00674102 Org: User:
Start: 04/30/08 End: - Due: -

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Phase: N/A Priority: Normal
NCT ID: NCT00051636 Org: User:
Start: 01/31/01 End: 04/30/11 Due: 04/30/12

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01552629 Org: User:
Start: 01/05/12 End: 08/28/13 Due: 08/28/14

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients

Phase: N/A Priority: Normal
NCT ID: NCT00995930 Org: User:
Start: 12/31/09 End: 02/28/14 Due: 02/28/15

A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02520752 Org: User:
Start: 12/10/15 End: 09/12/17 Due: 09/12/18

Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS

Phase: N/A Priority: Normal
NCT ID: NCT01757015 Org: User:
Start: 04/30/13 End: 04/30/14 Due: 04/30/15

Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT01019980 Org: User:
Start: 03/31/10 End: - Due: -

Specified Drug-use Survey of Leqvio for s.c. Injection.

Phase: N/A Priority: Normal
NCT ID: NCT06275724 Org: User:
Start: 03/04/24 End: 12/31/27 Due: 12/31/28

Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections

Phase: N/A Priority: Normal
NCT ID: NCT01184872 Org: User:
Start: 03/31/10 End: 03/31/11 Due: 03/31/12

A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT00651209 Org: User:
Start: 02/29/08 End: - Due: -

PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00093600 Org: User:
Start: 02/29/04 End: 06/30/11 Due: 06/30/12

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

Phase: N/A Priority: Normal
NCT ID: NCT04711902 Org: User:
Start: 06/24/21 End: 03/10/23 Due: 03/10/24

Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2

Phase: N/A Priority: Normal
NCT ID: NCT04935359 Org: User:
Start: 09/30/21 End: 08/13/24 Due: 08/13/25

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01828099 Org: User:
Start: 07/09/13 End: 01/07/24 Due: 01/07/25

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05114746 Org: User:
Start: 01/25/22 End: 01/31/28 Due: 01/31/29

Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01253629 Org: User:
Start: 11/30/10 End: 08/31/13 Due: 08/31/14

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01836471 Org: User:
Start: 05/31/13 End: 02/29/16 Due: 02/28/17

An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05120986 Org: User:
Start: 02/15/22 End: 05/15/23 Due: 05/15/24

Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00965094 Org: User:
Start: 12/31/09 End: 06/30/13 Due: 06/30/14

Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01609478 Org: User:
Start: 08/31/12 End: 07/31/13 Due: 07/31/14

Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT02060383 Org: User:
Start: 05/23/14 End: 03/26/18 Due: 03/26/19

Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01271166 Org: User:
Start: 10/31/07 End: - Due: -

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Phase: N/A Priority: Normal
NCT ID: NCT04971226 Org: User:
Start: 10/06/21 End: 01/18/28 Due: 01/18/29

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01574651 Org: User:
Start: 05/31/12 End: 04/30/13 Due: 04/30/14